# APRESOLINE-ESIDRIX
> **NDA012026** · New Drug Application · Sponsor: NOVARTIS
## Drug
- **FDA Application Number:** NDA012026
- **Application type:** New Drug Application
- **Brand name:** APRESOLINE-ESIDRIX
- **Generic name:** Hydralazine Hydrochloride
- **Active ingredients:** HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVARTIS
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012026)
---
*AI Analytics · CC0 1.0*